Hernia reduction following laparotomy using small stitch abdominal wall closure with or without mesh augmentation

Organizational Data

DRKS-ID:
DRKS00017517
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2019-06-24
Last update in DRKS:
2023-01-20
Registration type:
Prospective

Acronym/abbreviation of the study

HULC

URL of the study

No Entry

Brief summary in lay language

Incisional hernias are one of the most frequent complications following open abdominal surgeries with a rate of 10-30%. Incisional hernias cause additional costs and reduced quality of life. In Germany, more than 51,000 hernia surgeries are performed annually, with a recurrence rate of up to 30%. Therefore, the prevention of incisional hernias is crucial. Technical improvements in recent years, such as the prophylactic insertion of a mesh or the closure of the abdominal wall in the so-called small stitches technique significantly reduce the rate of incisional hernias. The aim of the HULC study is to investigate whether the combination of both techniques leads to an additional reduction of hernia rates. The primary end point is the hernia rate within 24 months after the operation. Other endpoints include surgical site infections, 30-day morbidity and quality of life.

Brief summary in scientific language

Incisional hernias (IHs) are among the most frequent complications following abdominal surgery causing substantial morbidity and mortality. Despite studies on the optimal closing technique for laparotomies IH rates following abdominal surgery are reported to be between 10-30% in RCTs and rise up to 36% in certain subgroups. In Germany, more than 51,000 IH repairs are performed each year making it one of the most frequent operations. A recent multicentre RCT has verified the superiority of abdominal closure in small stitches technique using a slowly absorbable suture and an increased suture-length to wound-length ratio of ≥ 4 in terms of reduced IH frequency in comparison to standard abdominal wall closure. Another promising strategy to prevent IHs is the placement of a prophylactic mesh during primary fascial closure. The objective of the HULC trial is to investigate whether prophylactic onlay mesh augmentation (OMA) in addition to abdominal wall closure in small stitches technique (SST) reduces the rate of IH formation in patients undergoing elective midline laparotomy compared to SST alone.

Health condition or problem studied

Free text:
Scheduled elective abdominal operation via a midline laparotomy
Healthy volunteers:
No

Interventions, Observational Groups

Arm 1:
Closure of the midline incision with a slowly absorbable monofilament suture in small stitches technique and additional onlay mesh augmentation using a polypropylene mesh
Arm 2:
Closure of the midline incision with a slowly absorbable monofilament suture in small stitch technique

Endpoints

Primary outcome:
Incisional hernia rate within 24 months after intervention as defined by the European Hernia Society
Secondary outcome:
1. Rate of superficial and deep surgical site infections according to Centers for Disease Control (CDC) criteria within one year in both groups; 2. Postoperative (30 day) morbidity according to the Dindo-Clavien classification; 3. Rate of non-infectious wound complications (hematoma, seroma) within 30 days after index Operation; 4. Rate of postoperative burst abdomen defined as missing continuity of the fascia in combination with wound dehiscence with consecutive reoperation within 30 days after index oeration; 5. Postoperative wound pain according to the numeric rating scale on postoperative days 5-7 and 30-35; 6. Quality of life measured with the SF-36 and EQ-5D questionnaires at baseline and at postoperative months 6, 12, and 24; 7. Length of postoperative hospital stay after index operation

Study Design

Purpose:
Treatment
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
  • Assessor
  • Patient/subject

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Multicenter study
Recruitment location(s):
  • University medical center Klinik für Allgemein-, Viszeral- und Thoraxchirurgie Hamburg
  • Medical center Chirurgische Klinik I, Allgemein-, Viszeral- und Gefäßchirurgie Aschaffenburg
  • University medical center Klinik für Allgemein-, Viszeral- und Thoraxchirurgie Hamburg
  • Medical center Chirurgische Klinik I, Allgemein-, Viszeral- und Gefäßchirurgie Aschaffenburg
  • Medical center Allgemein-, Viszeral- und Thoraxchirurgie Langen
  • University medical center Klinik für Allgemeine Chirurgie, Viszeral-, Gefäß- und Kinderchirurgie Homburg
  • University medical center Klinik für Allgemein-, Viszeral- und Transplantationschirurgie Heidelberg
  • University medical center Universitätsklinik für Viszerale, Gefäß- und Endokrine Chirurgie Halle/Saale
  • Medical center Chirurgie I Rheinland Klinikum Lukaskrankenhaus Neuss
  • University medical center Klinik für Allgemeine, Viszeral- und Transplantationschirurgie Tübingen
  • Medical center GRN-Klinik Sinsheim, Allgemein-, Viszeral- und Gefäßchirurgie Sinsheim
  • University medical center Klinik und Poliklinik für Allgemein-, Viszeral-, Transplantations-, Gefäß- und Kinderchirurgie Würzburg
  • Medical center Josephs-Hospital Warendorf, Klinik für Allgemein-Gefäß- und Visceralchirurgie Warendorf
  • Medical center Allgemein-, Viszeral- und Thoraxchirurgie, Bundeswehrkrankenhaus Ulm Ulm
  • University medical center Klinik für Allgemein-, Viszeral- und Transplantationschirurgie Klinikum der Universität München München
  • University medical center Klinik und Poliklinik für Chirurgie, Klinikum rechts der Isar der Technischen Universität München München
  • Medical center Klinik für Allgemein- und Viszeralchirurgie; Krankenhaus Bietigheim-Vaihingen Bietigheim

Recruitment period and number of participants

Planned study start date:
2019-07-01
Actual study start date:
2019-08-12
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
812
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
1. Elective abdominal operation via a midline laparotomy 2. Planned clean or clean-contaminated operations according to the Centre for Disease Control (CDC) definition 3. Patient age at least 18 years 4. Ability to understand the nature and extent of the trial and to give written informed consent. 5. Written informed consent 6. Life expectancy at least 2 years

Exclusion Criteria

1. American Society of Anaesthesiologists (ASA) grade > 3 2. Pregnant or lactating woman 3. Midline laparotomy within the last 60 days prior to trial intervention 4. Previous incisional abdominal hernia or fascial dehiscence 5. Planned relaparotomy via the midline incision within 2 years after trial intervention 6. Concurrent abdominal wall infections 7. Participation in another intervention-trial with interference of intervention and/or outcome of this study

Addresses

Primary Sponsor

Address:
Universitätsklinikum Ulm
Albert-Einstein-Allee 29
89081 Ulm
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Klinik für Allgemein- und Viszeralchirurgie
Prof. Dr. med. André L. Mihaljevic
Albert-Einstein-Allee 23
89081 Ulm
Germany
Telephone:
0731-50053502
Fax:
0731-50053503
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Klinik für Allgemein- und Viszeralchirurgie
Prof. Dr. med. André L. Mihaljevic
Albert-Einstein-Allee 23
89081 Ulm
Germany
Telephone:
0731-50053502
Fax:
0731-50053503
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Klinik für Allgemein- und Viszeralchirurgie
Prof. Dr. med. André L. Mihaljevic
Albert-Einstein-Allee 23
89081 Ulm
Germany
Telephone:
0731-50053502
Fax:
0731-50053503
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
Deutsche Forschungsgemeinschaft
Kennedyallee 40
53175 Bonn
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.dfg.de

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission der Medizinischen Fakultät Heidelberg
Alte Glockengießerei 11/1
69115 Heidelberg
Germany
Telephone:
+49-6221-338220
Fax:
+49-6221-3382222
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2019-05-07
Ethics committee number:
S-361/2019
Vote of the Ethics Committee:
Approved
Date of the vote:
2019-06-11

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
U1111-1233-8181
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry